|
Volumn 14, Issue 2, 2002, Pages 213-218
|
Pharmacologic treatment of adolescent depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CHLORDIAZEPOXIDE;
CITALOPRAM;
DESIPRAMINE;
DEXTROMETHORPHAN;
FLUOXETINE;
FLUVOXAMINE;
FLUVOXAMINE MALEATE;
MONOAMINE OXIDASE INHIBITOR;
NEFAZODONE;
NORADRENALIN UPTAKE INHIBITOR;
NORTRIPTYLINE;
PAROXETINE;
PETHIDINE;
PHENELZINE;
PHENOBARBITAL;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TYRAMINE;
VENLAFAXINE;
ADOLESCENT;
ADOLESCENT DISEASE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG INDUCED DISEASE;
HUMAN;
HYPERTENSION;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
PSYCHIATRIC DIAGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SOMNOLENCE;
SYMPTOMATOLOGY;
TACHYCARDIA;
URINE RETENTION;
VISUAL IMPAIRMENT;
XEROSTOMIA;
ADOLESCENT;
ADULT;
ANTIDEPRESSIVE AGENTS;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CLINICAL TRIALS;
DEPRESSIVE DISORDER;
HUMANS;
INCIDENCE;
MONOAMINE OXIDASE INHIBITORS;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 0036117764
PISSN: 10408703
EISSN: None
Source Type: Journal
DOI: 10.1097/00008480-200204000-00012 Document Type: Review |
Times cited : (3)
|
References (29)
|